Helmut Schühsler,
Techno Venture Management (TVM)

Dr. Helmut M. Schühsler has been responsible for over 20 TVM investments in life science companies, and has since 1990 served on various committees, among others as a member of the Senate of the Hermann von Helmholtz-Gemeinschaft Deutscher Forschungszentren (HGF).

Currently he is a board member at the following life science companies: Curacyte AG, Develogen AG, Ingenium Pharmaceuticals AG, Intercell AG, Morphochem AG, and SelectX, Inc.

Dr. Schühsler also is a member of the Supervisory Board of the European Venture Capital and Private Equity Association (EVCA), and a board member of Garching Innovation GmbH, the technology transfer institution of the Max Planck Society, and of Ascenion GmbH, the technology transfer organisation of several HGF institutes.

Prior to TVM, he was an Investment Manager at Horizonte Venture Management in Vienna. Dr. Schühsler wrote his doctoral thesis at the Economics University of Vienna in the area of business administration.


close window